Proteomic Screen IDs Potential Use for GlaxoSmithKline Inhibitor in Treating Leukemia

		Cancer Friends Network > Types of Cancer > Leukemia
Proteomic Screen IDs Potential Use for GlaxoSmithKline Inhibitor in Treating Leukemia

LinkBack

Thread Tools

Display Modes

#1 (permalink)

10-10-2011, 08:23 AM

cancerfr

Administrator

Join Date: Sep 2008

Posts: 47,390

Proteomic Screen IDs Potential Use for GlaxoSmithKline Inhibitor in Treating Leukemia

Research published this week by a team including scientists from proteomics firm Cellzome and GlaxoSmithKline suggests that the small molecule inhibitor I-BET151 could be useful as a treatment for MLL-fusion leukemia.

Tim Pearson

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On Forum Rules

All times are GMT. The time now is 02:54 PM.

CancerFriends.net